The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.
Vascular aspects of the Ehlers-Danlos Syndromes
Abstract
The Ehlers-Danlos Syndromes comprise a heterogeneous group of rare monogenic conditions that are characterized by joint hypermobility, skin and vascular fragility and generalized connective tissue friability. The latest classification recognizes 13 clinical subtypes, with mutations identified in 19 different genes. Besides defects in fibrillar collagens (collagen types I, III and V), their modifying enzymes (ADAMTS-2, lysylhydroxylase 1 (LH1)), and molecules involved in collagen folding (FKBP22), defects have recently been identified in other constituents of the extracellular matrix (e.g. Tenascin-X, collagen type XII), enzymes involved in glycosaminoglycan biosynthesis (β4GalT7 and β3GalT6), dermatan 4-O-sulfotransferase-1 (D4ST1), dermatan sulfate epimerase (DSE)), (putative) transcription factors (ZNF469, PRDM5), components of the complement pathway (C1r, C1s) and an intracellular Zinc transporter (ZIP13). Easy bruising is, to a variable degree, present in all subtypes of EDS. A variable bleeding tendency, manifesting e.g. as gum bleeding, menometrorraghia, postnatal or peri-operative hemorrhage is observed in many EDS-patients of varying EDS subtypes. Life-threatening arterial aneurysms, dissections and ruptures of medium-sized and large arteries are a hallmark of the vascular subtype of EDS, caused by a molecular defect in collagen type III, an important constituent of blood vessel walls and hollow organs. They may however also occur in other EDS subtypes, especially in classical EDS, caused by defects in type V collagen or, rarely, type I collagen, and in kyphoscoliotic EDS, caused by defects in LH1 or FKBP22. These manifestations of vascular fragility and bleeding are usually attributed to fragility of the blood vessel walls and the perivascular connective tissues, but the molecular pathomechanisms underlying these complications are poorly studied. This review summarizes current knowledge on manifestations of vascular fragility in the different EDS subtypes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Col3a1 deficient mice show a reduced lifespan mainly due to arterial ruptures and abnormalities of collagen fibril organization in several collagen-rich organs, i.e., aorta, skin, lung, and bowel [10].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [10]
Citations
Cites
The 2017 international classification of the Ehlers–Danlos syndromes
Malfait, F., Francomano, C., Byers, P., Belmont, J., Berglund, B., Black, J., Bloom, L., Bowen, J. M., Brady, A. F., Burrows, N. P., et al. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31552 · Cited by 1,936
Self-citationClinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type
Pepin, M., Schwarze, U., Superti-Furga, A., & Byers, P. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421001 · Cited by 1,344
Kadler, K. E., Baldock, C., Bella, J., & Boot-Handford, R. (2007) · Journal of Cell Science · doi:10.1242/jcs.03453 · Cited by 887
Procollagen trafficking, processing and fibrillogenesis
Canty‐Laird, E. G., & Kadler, K. E. (2005) · Journal of Cell Science · doi:10.1242/jcs.01731 · Cited by 797
Liu, X., Wu, H., Byrne, M., Krane, S., & Jaenisch, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1852 · Cited by 614
Gordon, M. K., & Hahn, R. A. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0844-4 · Cited by 548
Type V collagen controls the initiation of collagen fibril assembly
Wenstrup, R. J., Florer, J. B., Brunskill, E. W., Bell, S. M., Chervoneva, I., & Birk, D. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409622200 · Cited by 545
Iozzo, R. V. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709108551 · Cited by 501
Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly
Birk, D. E. (2001) · Micron · doi:10.1016/s0968-4328(00)00043-3 · Cited by 438
Oderich, G. S., Panneton, J. M., Bower, T. C., Lindor, N. M., Cherry, K. J., Noel, A. A., Kalra, M., Sullivan, T. M., & Gloviczki, P. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.03.053 · Cited by 433
A Heritable Disorder of Connective Tissue: Hydroxylysine-Deficient Collagen Disease
Pinnell, S. R., Krane, S. M., Kenzora, J. E., & Glimcher, M. J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197205112861901 · Cited by 414
Ong, K.-T., Perdu, J., Backer, J. F. A. D., Bozec, E., Collignon, P., Emmerich, J., Fauret‐Amsellem, A., Fiessinger, J., Germain, D. P., Georgesco, G., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60960-9 · Cited by 410
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency
Schalkwijk, J., Zweers, M. C., Steijlen, P. M., Dean, W. B., Taylor, G., van Vlijmen, I. M., van Haren, B., Miller, W. L., & Bristow, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002939 · Cited by 391
Collagen type I and type V are present in the same fibril in the avian corneal stroma.
Birk, D. E., Fitch, J. M., Babiarz, J. P., & Linsenmayer, T. F. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.106.3.999 · Cited by 391
Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome
Byers, P. H., Belmont, J., Black, J., De Backer, J., Frank, M., Jeunemaitre, X., Johnson, D., Pepin, M., Robert, L., Sanders, L., et al. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31553 · Cited by 381
Colige, A., Sieron, A. L., Li, S.-W., Schwarze, U., Petty, E., Wertelecki, W., Wilcox, W., Krakow, D., Cohn, D. H., Reardon, W., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302504 · Cited by 370
Tenascin-X deficiency is associated with Ehlers-Danlos syndrome
Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J. (1997) · Nature Genetics · doi:10.1038/ng0997-104 · Cited by 366
Peptidylprolyl Cis / Trans Isomerases (Immunophilins): Biological Diversity - Targets - Functions
Galat, A. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033451862 · Cited by 360
Pepin, M. G., Schwarze, U., Rice, K. M., Liu, M., Leistritz, & Byers, P. H. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.72 · Cited by 313
Platelet adhesion signalling and the regulation of thrombus formation
Gibbins, J. M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01325 · Cited by 296
Scott, I. C., Blitz, I. L., Pappano, W. N., Imamura, Y., Clark, T. G., Steiglitz, B. M., Thomas‐Virnig, C. L., Maas, S. A., Takahara, K., Cho, K. W. Y., et al. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9383 · Cited by 278
Type III collagen can be present on banded collagen fibrils regardless of fibril diameter.
Keene, D. R., Sakai, L. Y., Bächinger, H. P., & Burgeson, R. E. (1987) · The Journal of Cell Biology · doi:10.1083/jcb.105.5.2393 · Cited by 272
The Ehlers–Danlos syndromes, rare types
Brady, A. F., Demirdas, S., Fournel‐Gigleux, S., Ghali, N., Giunta, C., Kapferer‐Seebacher, I., Kosho, T., Mendoza‐Londono, R., Pope, M. F., Rohrbach, M., et al. (2017) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31550 · Cited by 258
Self-citationFrank, M., Albuisson, J., Ranque, B., Golmard, L., Mazzella, J.-M., Bal-Theoleyre, L., Fauret, A.-L., Mirault, T., Denarié, N., Mousseaux, E., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.32 · Cited by 248
Gubbiotti, M. A., Vallet, S. D., Ricard‐Blum, S., & Iozzo, R. V. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.09.009 · Cited by 237
Another look at collagen V and XI molecules
Fichard, A., Kleman, J.-P., & Ruggiero, F. (1995) · Matrix Biology · doi:10.1016/s0945-053x(05)80001-0 · Cited by 219
Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation.
Pihlajaniemi, T. A., Dickson, L. A., Pope, F. M., KORHONEN, V. R., Nicholls, A. C., Prockop, D. J., & Myers, J. C. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90635-6 · Cited by 209
Ehlers-Danlos syndrome, classical type
Bowen, J. M., Sobey, G. J., Burrows, N. P., Colombi, M., Lavallee, M. E., Malfait, F., & Francomano, C. A. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31548 · Cited by 184
Self-citationA molecular ensemble in the rER for procollagen maturation
Ishikawa, Y., & Bächinger, H. P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.04.008 · Cited by 183
Pregnancy-related deaths and complications in women with vascular Ehlers–Danlos syndrome
Murray, M. L., Pepin, M. G., Peterson, S., & Byers, P. H. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.53 · Cited by 183
Murine Model of the Ehlers-Danlos Syndrome
WENSTRUP, R. J., Florer, J. B., Davidson, J. M., Phillips, C. L., Pfeiffer, B. J., Menezes, D. W., Chervoneva, I., & Birk, D. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511528200 · Cited by 180
Colige, A., Li, S., Sieroń, A. L., Nusgens, B., Prockop, D. J., & Lapiere, C. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2374 · Cited by 171
Classical Ehlers-Danlos Syndrome Caused by a Mutation in Type I Collagen
Nuytinck, L., Freund, M., Lagae, L., Pierard, G. E., Hermanns-Le, T., & De Paepe, A. (2000) · The American Journal of Human Genetics · doi:10.1086/302859 · Cited by 169
Neuromuscular involvement in various types of Ehlers–Danlos syndrome
Voermans, N. C., van Alfen, N., Pillen, S., Lammens, M. M. Y., Schalkwijk, J., Zwarts, M. J., van Rooij, I. A. L. M., Hamel, B. C. J., & van Engelen, B. G. M. (2009) · Annals of Neurology · doi:10.1002/ana.21643 · Cited by 168
Malfait, F., Symoens, S., De Backer, J., Hermanns-Lê, T., Sakalihasan, N., Lapière, C. M., Coucke, P., & De Paepe, A. (2007) · Human Mutation · doi:10.1002/humu.20455 · Cited by 167
Self-citationSymoens, S., Syx, D., Malfait, F., Callewaert, B., De Backer, J., Vanakker, O., Coucke, P., & De Paepe, A. (2012) · Human Mutation · doi:10.1002/humu.22137 · Cited by 165
Self-citationThe procollagen N-proteinases ADAMTS2, 3 and 14 in pathophysiology
Bekhouche, M., & Colige, A. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.04.001 · Cited by 163
Baumann, M., Giunta, C., Krabichler, B., Rüschendorf, F., Zoppi, N., Colombi, M., Bittner, R. E., Quijano-Roy, S., Muntoni, F., Cirak, S., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.12.004 · Cited by 162
Takahara, K., Lyons, G. E., & Greenspan, D. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31672-7 · Cited by 159
Krane, S. M., Pinnell, S. R., & Erbe, R. W. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.10.2899 · Cited by 157
Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome
Miyake, N., Kosho, T., Mizumoto, S., Furuichi, T., Hatamochi, A., Nagashima, Y., Arai, E., Takahashi, K., Kawamura, R., Wakui, K., et al. (2010) · Human Mutation · doi:10.1002/humu.21300 · Cited by 156
Haußer, I., & Anton‐Lamprecht, I. (1994) · Human Genetics · doi:10.1007/bf00201664 · Cited by 147
Prevalence of aortic root dilation in the Ehlers-Danlos syndrome
WENSTRUP, R. J., Meyer, R. A., Lyle, J. S., Hoechstetter, L., Rose, P. S., Levy, H. P., & Francomano, C. A. (2002) · Genetics in Medicine · doi:10.1097/00125817-200205000-00003 · Cited by 145
Malfait, F., Kariminejad, A., Van Damme, T., Gauche, C., Syx, D., Merhi-Soussi, F., Gulberti, S., Symoens, S., Vanhauwaert, S., Willaert, A., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.016 · Cited by 142
Self-citationSchwarze, U., Atkinson, M., Hoffman, G. G., Greenspan, D. S., & Byers, P. H. (2000) · The American Journal of Human Genetics · doi:10.1086/302933 · Cited by 136
Ritelli, M., Dordoni, C., Venturini, M., Chiarelli, N., Quinzani, S., Traversa, M., Zoppi, N., Vascellaro, A., Wischmeijer, A., Manfredini, E., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-58 · Cited by 134
Shalhub, S., Black, J. H., Cecchi, A. C., Zhi, X., Griswold, B. F., Safi, H. J., Milewicz, D. M., & McDonnell, N. B. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.01.070 · Cited by 132
Romanic, A. M., Adachi, E., Kadler, K. E., Hojima, Y., & Prockop, D. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98956-8 · Cited by 130
COL5A1 Haploinsufficiency Is a Common Molecular Mechanism Underlying the Classical Form of EDS
WENSTRUP, R. J., Florer, J. B., Willing, M. C., Giunta, C., Steinmann, B. U., Young, F., Susic, M., & Cole, W. G. (2000) · The American Journal of Human Genetics · doi:10.1086/302930 · Cited by 128
Colige, A., Ruggiero, F., Vandenberghe, I. H. M., Dubail, J., Kesteloot, F., BEEUMEN, J. V., Beschin, A., Brys, L., Lapiere, C. M., & Nusgens, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506458200 · Cited by 125
Ehlers-Danlos syndrome type VI: Clinical manifestations of collagen lysyl hydroxylase deficiency
Wenstrup, R. J., Murad, S., & Pinnell, S. R. (1989) · The Journal of Pediatrics · doi:10.1016/s0022-3476(89)80839-x · Cited by 124
Font, B., Eichenberger, D., Rosenberg, L. M., & REST, M. V. D. (1996) · Matrix Biology · doi:10.1016/s0945-053x(96)90137-7 · Cited by 123
Kapferer-Seebacher, I., Pepin, M., Werner, R., Aitman, T. J., Nordgren, A., Stoiber, H., Thielens, N., Gaboriaud, C., Amberger, A., Schossig, A., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.08.019 · Cited by 123
Malfait, F., Syx, D., Vlummens, P., Symoens, S., Nampoothiri, S., Hermanns-Lê, T., Van Laer, L., & De Paepe, A. (2010) · Human Mutation · doi:10.1002/humu.21355 · Cited by 122
Self-citationThe clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta.
Nicholls, A. C., Osse, G., Schloon, H., Lenard, H. G., Deak, S. B., Myers, J. C., Prockop, D. J., Weigel, W. R., Fryer, P. R., & Pope, F. M. (1984) · Journal of Medical Genetics · doi:10.1136/jmg.21.4.257 · Cited by 121
Urinary pyridinoline cross-links in Ehlers-Danlos syndrome type VI.
Steinmann, B., Eyre, D. R., & Shao, P. (1995) · PubMed · Cited by 113
Transforming Growth Factor-β Induces Secretion of Activated ADAMTS-2
Wang, W.-M., Lee, S., Steiglitz, B. M., Scott, I. C., Lebares, C. C., Allen, M. L., Brenner, M. C., Takahara, K., & Greenspan, D. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300767200 · Cited by 109
Hyland, J. C., Ala‐Kokko, L., Royce, P., Steinmann, B. U., Kivirikko, K. I., & Myllylä, R. (1992) · Nature Genetics · doi:10.1038/ng1192-228 · Cited by 108
Müller, T., Mizumoto, S., Suresh, I., Komatsu, Y., Vodopiutz, J., Dündar, M., Straub, V. W., Lingenhel, A., Melmer, A., Lechner, S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt227 · Cited by 107
Rohrbach, M., Vandersteen, A., Yiş, U., Serdaroglu, G., Ataman, E., Chopra, M., Garcia, S., Jones, K., Kariminejad, A., Kraenzlin, M., et al. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-46 · Cited by 106
Collagen XII Interacts with Avian Tenascin-X through Its NC3 Domain*
Veit, G., Hansen, U., Keene, D., Bruckner, P., Chiquet-Ehrismann, R., Chiquet, M., & Koch, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603147200 · Cited by 104
Smith, L. T., Schwarze, U., Goldstein, J., & Byers, P. H. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12286441 · Cited by 99
Malfait, F., Symoens, S., Goemans, N., Gyftodimou, Y., Holmberg, E., López‐González, V., Mortier, G. R., Nampoothiri, S., Petersen, M. B., & Paepe, A. D. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-78 · Cited by 98
Self-citationBleeding in the heritable connective tissue disorders: Mechanisms, diagnosis and treatment
Malfait, F., & Paepe, A. D. (2009) · Blood Reviews · doi:10.1016/j.blre.2009.06.001 · Cited by 94
Self-citationEchocardiographic findings in classical and hypermobile Ehlers–Danlos syndromes
McDonnell, N. B., Gorman, B. L., Mandel, K. W., Schurman, S. H., Assanah‐Carroll, A., Mayer, S. A., Najjar, S. S., & Francomano, C. A. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31035 · Cited by 92
Takaluoma, K., Hyry, M., Lantto, J., Sormunen, R. T., Bank, R. A., Kivirikko, K. I., Myllyharju, J., & Soininen, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608830200 · Cited by 92
Kosho, T., Miyake, N., Hatamochi, A., Takahashi, J., Kato, H., Miyahara, T., Igawa, Y., Yasui, H., Ishida, T., Ono, K., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33498 · Cited by 88
Mayer, S. A., Rubin, B. S., Starman, B. J., & Byers, P. H. (1996) · Neurology · doi:10.1212/wnl.47.2.552 · Cited by 86
Syx, D., Van Damme, T., Symoens, S., Maiburg, M. C., van de Laar, I., Morton, J., Suri, M., Del Campo, M., Hausser, I., Hermanns-Lê, T., et al. (2015) · Human Mutation · doi:10.1002/humu.22774 · Cited by 84
Self-citationAtzinger, C. L., Meyer, R. A., Khoury, P. R., Gao, Z., & Tinkle, B. T. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.11.023 · Cited by 83
Smith, L. B., Hadoke, P. W. F., Dyer, E., Denvir, M. A., Brownstein, D., Miller, E., Nelson, N., Wells, S., Cheeseman, M., & Greenfield, A. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq356 · Cited by 81
(1977) · PubMed · Cited by 79
D'hondt, S., Guillemyn, B., Syx, D., Symoens, S., De Rycke, R., Vanhoutte, L., Toussaint, W., Lambrecht, B. N., De Paepe, A., Keene, D. R., et al. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.008 · Cited by 79
Self-citationGiunta, C., Randolph, A. E., & Steinmann, B. U. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.04.014 · Cited by 78
Chiarelli, N., Carini, G., Zoppi, N., Dordoni, C., Ritelli, M., Venturini, M., Castori, M., & Colombi, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161347 · Cited by 78
Serious ophthalmological complications in the Ehlers-Danlos syndrome.
Beighton, P. (1970) · British Journal of Ophthalmology · doi:10.1136/bjo.54.4.263 · Cited by 75
Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers–Danlos syndrome (EDS VIA)
Giunta, C., Randolph, A. E., Al‐Gazali, L. I., Brunner, H. G., KRAENZLIN, M. E., & Steinmann, B. U. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30529 · Cited by 71
Ehlers–Danlos syndrome: A showcase of conditions that lead to understanding matrix biology
Byers, P. H., & Murray, M. L. (2014) · Matrix Biology · doi:10.1016/j.matbio.2013.07.005 · Cited by 68
Cabral, W. A., Makareeva, E., Letocha, A. D., Scribanu, N., Fertala, A., Steplewski, A., Keene, D. R., Persikov, A. V., Leikin, S., & Marini, J. C. (2007) · Human Mutation · doi:10.1002/humu.20456 · Cited by 68
Tenascin‐X deficiency in autosomal recessive Ehlers–Danlos syndrome
Lindor, N. M., & Bristow, J. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30671 · Cited by 67
The phenotype of the musculocontractural type of Ehlers‐Danlos syndrome due to CHST14 mutations
Janecke, A. R., Li, B., Boehm, M., Krabichler, B., Rohrbach, M., Müller, T., Fuchs, I., Golas, G., Katagiri, Y., Ziegler, S. G., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37383 · Cited by 66
Interactions of human tenascin-X domains with dermal extracellular matrix molecules
Egging, D. F., van den Berkmortel, F., Taylor, G. D., Bristow, J., & Schalkwijk, J. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0706-9 · Cited by 66
Diversity in the processing events at the N‐terminus of type‐V collagen
Moradi‐Améli, M., Rousseau, J., Kleman, J.-P., Champliaud, M.-F., Boutillon, M., Bernillon, J., Wallach, J., & REST, M. V. D. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18815.x · Cited by 64
Familial Ehlers‐Danlos syndrome with lethal arterial events caused by a mutation in COL5A1
Monroe, G. R., Harakaľová, M., van der Crabben, S. N., Majoor‐Krakauer, D. F., Bertoli‐Avella, A. M., Moll, F. L., Oranen, B. I., Dooijes, D., Vink, A., Knoers, N. V. A. M., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36997 · Cited by 61
Arterial rupture in classic Ehlers–Danlos syndrome with COL5A1 mutation
Borck, G., Beighton, P., Wilhelm, C., Kohlhase, J., & Kubisch, C. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33541 · Cited by 60
Demirdas, S., Dulfer, E., Robert, L., Kempers, M., van Beek, D., Micha, D., van Engelen, B. G., Hamel, B., Schalkwijk, J., Loeys, B., et al. (2017) · Clinical Genetics · doi:10.1111/cge.12853 · Cited by 60
Homozygosity for a null allele of COL3A1 results in recessive Ehlers–Danlos syndrome
Plancke, A., Holder‐Espinasse, M., Rigau, V., Manouvrier‐Hanu, S., Claustres, M., & Kien, P. K. V. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.76 · Cited by 52
Ishikawa, Y., & Bächinger, H. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.561944 · Cited by 52
Transforming growth factor-β and inflammation in vascular (type IV) Ehlers-Danlos syndrome
Morissette, R., Schoenhoff, F., Xu, Z., Shilane, D. A., Griswold, B. F., Chen, W., Yang, J., Zhu, J., Fert-Bober, J., Sloper, L., et al. (2014) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000280 · Cited by 51
The Haploinsufficient Col3a1 Mouse as a Model for Vascular Ehlers-Danlos Syndrome
Cooper, T. K., Zhong, Q., Krawczyk, M., Tae, H.-J., Müller, G. A., Schubert, R., Myers, L. A., Dietz, H. C., Talan, M. I., & Briest, W. (2010) · Veterinary Pathology · doi:10.1177/0300985810374842 · Cited by 51
Expanding the clinical and mutational spectrum of the Ehlers–Danlos syndrome, dermatosparaxis type
Van Damme, T., Colige, A., Syx, D., Giunta, C., Lindert, U., Rohrbach, M., Aryani, O., Alanay, Y., Simsek-Kiper, P. Ö., Kroes, H. Y., et al. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.188 · Cited by 51
Self-citationVandervore, L. V., Stouffs, K., Tanyalçin, I., Vanderhasselt, T., Roelens, F., Holder‐Espinasse, M., Jørgensen, A., Pepin, M. G., Petit, F., Kien, P. K. V., et al. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104421 · Cited by 48
Jørgensen, A., Fagerheim, T., Rand‐Hendriksen, S., Lunde, P. I., Vorren, T., Pepin, M. G., Leistritz, D. F., & Byers, P. H. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.181 · Cited by 46
Giunta, C., Baumann, M., Fauth, C., Lindert, U., Abdalla, E. M., Brady, A. F., Collins, J. J., Dastgir, J., Donkervoort, S. C., Ghali, N., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.70 · Cited by 43
Superior mesenteric artery aneurysm in a 9‐year‐old boy with classical Ehlers–Danlos syndrome
de Leeuw, K., Goorhuis, J. F., Tielliu, I. F. J., Symoens, S., Malfait, F., Paepe, A. D., van Tintelen, J. P., & Hulscher, J. B. F. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34420 · Cited by 42
Self-citationPark, A. C., Phan, N., Massoudi, D., Liu, Z., Kernien, J. F., Adams, S. M., Davidson, J. M., Birk, D. E., Liu, B., & Greenspan, D. S. (2017) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.06.006 · Cited by 40
Ehlers Danlos Syndrome: An Unusual Presentation You Need to Know about
Karaa, A., & Stoler, J. M. (2013) · Case Reports in Pediatrics · doi:10.1155/2013/764659 · Cited by 39
Angiotensin II Promotes Thoracic Aortic Dissections and Ruptures in Col3a1 Haploinsufficient Mice
Faugeroux, J., Nematalla, H., Li, W., Clément, M., Robidel, E., Frank, M., Curis, E., Ait‐Oufella, H., Caligiuri, G., Nicoletti, A., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00974 · Cited by 39
Mehta, S., Dhar, S. U., & Birnbaum, Y. (2012) · International Journal of Angiology · doi:10.1055/s-0032-1325118 · Cited by 36
Gaines, R., Tinkle, B. T., Halandras, P. M., Al-Nouri, O., Crisostomo, P., & Cho, J. S. (2015) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2014.10.036 · Cited by 34
Müller, G. A., Hansen, U. J., Zhi, X., Griswold, B. F., Talan, M. I., McDonnell, N. B., & Briest, W. (2011) · The FASEB Journal · doi:10.1096/fj.11-182162 · Cited by 34
Jarvis, G. E., Bihan, D. G., Hamaia, S. W., Pugh, N., Ghevaert, C., Pearce, A. C., Hughes, C. E., Watson, S. P., Ware, J. L., Rudd, C. E., et al. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04567.x · Cited by 33
Sasikumar, P., AlOuda, K. S., Kaiser, W. J., Holbrook, L., Kriek, N., Unsworth, A. J., Bye, A. P., Sage, T., Ushioda, R., Nagata, K., et al. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13998 · Cited by 33
Tae, H., Marshall, S. A., Zhang, J., Wang, M., Briest, W., & Talan, M. I. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.197020 · Cited by 31
Dembure, P. P., Priest, J. H., Snoddy, S. C., & Elsas, L. J. (1984) · Europe PMC (PubMed Central) · Cited by 30
Park, A. C., Phillips, C. L., Pfeiffer, F. M., Roenneburg, D. A., Kernien, J. F., Adams, S. M., Davidson, J. M., Birk, D. E., & Greenspan, D. S. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.03.022 · Cited by 30
Lund, A. M., Joensen, F., Christensen, E., Dunø, M., Skovby, F., & Schwartz, M. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00926.x · Cited by 29
Hendriks, A. G. M., Voermans, N., Schalkwijk, J., Hamel, B., & van Rossum, M. V. (2012) · Clinical Dysmorphology · doi:10.1097/mcd.0b013e32834c4bb7 · Cited by 29
Horn, D., Siebert, E., Seidel, U., Rost, I., Mayer, K., Jamra, R. A., Mitter, D., & Kornak, U. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38345 · Cited by 29
Briest, W., Cooper, T. K., Tae, H.-J., Krawczyk, M., McDonnell, N. B., & Talan, M. I. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.177782 · Cited by 25
Otero, L. J., Brown, R. M., & Brown, G. K. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:2 · Cited by 24
FKBP14 ‐related Ehlers‐Danlos syndrome: Expansion of the phenotype to include vascular complications
Murray, M. L., Yang, M., Fauth, C., & Byers, P. H. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36492 · Cited by 24
A Case of Ehlers-Danlos Syndrome Type VIA With a Novel PLOD1 Gene Mutation
Tosun, A. F., Kurtgöz, S., Dursun, Ş., & Bozkurt, G. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.06.020 · Cited by 24
Raux, G., Gantier, R., Martin, C., Pothin, Y., Brice, A., Frébourg, T., & Campion, D. (2000) · Human Mutation · doi:10.1002/1098-1004(200007)16:1 · Cited by 23
Yasuda, S., Imoto, K., Uchida, K., Machida, D., Yanagi, H., Sugiura, T., Kurosawa, K., & Masuda, M. (2013) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2013.01.004 · Cited by 22
Dordoni, C., Ciaccio, C., Venturini, M., Calzavara‐Pinton, P., Ritelli, M., & Colombi, M. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37728 · Cited by 20
Haralson, M. A., Mitchell, W. M., Rhodes, R. K., & Miller, E. J. (1984) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(84)90182-6 · Cited by 19
Gök, E., Göksel, O., Alpagut, U., & Dayıoğlu, E. (2012) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2012.08.004 · Cited by 17
Yeowell, H. N., Walker, L. C., Murad, S., & Pinnell, S. R. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0319 · Cited by 13
Ultrastructural scoring of skin biopsies for diagnosis of vascular Ehlers–Danlos syndrome
Ong, K.-T., Plauchu, H., Peyrol, S., Roux, É., Errazuriz-Cerda, E., Kien, P. K. V., Arbeille, B., Gaulier, A., Georgescou, G., Collignon, P., et al. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1233-z · Cited by 13
Critical care of kyphoscoliotic type Ehlers-Danlos syndrome with recurrent vascular emergencies
Busch, A., Suellner, J., Anger, F., Meir, M., Kickuth, R., Lorenz, U., & Wildenauer, R. (2014) · VASA · doi:10.1024/0301-1526/a000352 · Cited by 11
Biochemical investigation of cells from keratoconus and normal cornea
Ihme, A., Krieg, T., Müller, R. K., & Wollensak, J. (1983) · Experimental Eye Research · doi:10.1016/0014-4835(83)90100-8 · Cited by 10
A case of Ehlers Danlos syndrome type VI.
Salavoura, K., Valari, M., Kolialexi, A., Mavrou, A., & Kitsiou, S. (2006) · PubMed · Cited by 8
Treatment of Aneurysmal Aberrant Right Subclavian Artery with Triple-Barrel Stent Graft
Schwein, A., Georg, Y., Ohana, M., Delay, C., Lejay, A., Thaveau, F., & Chakfé, N. (2015) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2014.10.035 · Cited by 8
Willaert, A., Symoens, S., Malfait, F., Gevaert, K., Coucke, P. J., & Paepe, A. D. (2008) · Ghent University Academic Bibliography (Ghent University) · Cited by 1
Self-citationMalfait, F., Willaert, A., Symoens, S., Coucke, P. J., & Paepe, A. D. (2008) · Ghent University Academic Bibliography (Ghent University) · Cited by 1
Self-citationEhlers-Danlos syndromes: Revised nosology, Villefranche, 1997
Beighton, P., Paepe, A. D., Steinmann, B., Tsipouras, P., & Wenstrup, R. J. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980428)77:1
Research works printed but not linked: 2
- Beighton, 1998, Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK), Am. J. Med. Genet., 77, 31, 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O · DOI · Paper page
- Malfait, 2007, Three arginine to cysteine substitutions 4 in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood, Hum. Mutat., 28, 387, 10.1002/humu.20455 · DOI · Paper page
Cited by
Sorted by citations
Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases
Kuivaniemi, H., & Tromp, G. (2019) · Gene · doi:10.1016/j.gene.2019.05.003 · Cited by 444
Intracranial Aneurysms: Pathology, Genetics, and Molecular Mechanisms
Xu, Z., Rui, Y., Hagan, J. P., & Kim, D. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08537-7 · Cited by 155
Extracellular matrix dynamics in vascular remodeling
Ma, Z., Mao, C., Jia, Y., Fu, Y., & Kong, W. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00147.2020 · Cited by 129
Wang, C., Brisson, B. K., Terajima, M., Li, Q., Hoxha, K., Han, B., Goldberg, A., Liu, X. S., Marcolongo, M. S., Enomoto‐Iwamoto, M., et al. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.10.001 · Cited by 125
The Mechanism and Role of ADAMTS Protein Family in Osteoarthritis
Li, T., Peng, J., Li, Q., Shu, Y., Zhu, P., & Hao, L. (2022) · Biomolecules · doi:10.3390/biom12070959 · Cited by 109
Metadata
- Authors
- Malfait, F.
- Affiliations
- Ghent University Hospital (BE)
- Corresponding author
- Malfait, Fransiska
- ORCID
- Malfait, Fransiska
- Venue
- Matrix Biology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 71-72
- Pages
- 380-395
- ISSN
- 0945-053X (ISSN-L)
- OpenAlex
- W2800944293
- Cited by
- 113
- References
- 128
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 15 · 2023: 12 · 2022: 10 · 2021: 14 · 2020: 22 · 2019: 19 · 2018: 2
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Matrix Biology (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Vlaamse regering
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- Ehlers-Danlos syndrome, vascular fragility, arterial aneurysm, arterial dissection, arterial rupture, bleeding tendency, easy bruising, type III collagen, type V collagen, connective tissue diseases, glycosaminoglycan synthesis
- MeSH terms
- Collagen, Ehlers-Danlos Syndrome, Extracellular Matrix, Humans, Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase, Mutation, Vascular Diseases, Genetic Predisposition to Disease, Tacrolimus Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review